Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: The case of previous abdominal surgery. Results from a prospective trial

Published on May 1, 2012in Radiotherapy and Oncology4.856
· DOI :10.1016/J.RADONC.2012.03.012
Riccardo Valdagni51
Estimated H-index: 51
,
Vittorio Vavassori18
Estimated H-index: 18
+ 10 AuthorsC. Fiorino7
Estimated H-index: 7
(UniSR: Vita-Salute San Raffaele University)
Sources
Abstract
Purpose: To evaluate and discuss the role of specific types of abdominal surgery (SURG) before radical radiation therapy as a risk factor for late rectal toxicity in prostate cancer patients. Methods: Results concerning questionnaire-based scored late bleeding and faecal incontinence in 718 patients with a complete follow-up of 36 months were analysed, focusing on the impact of specific pre-radiotherapy abdominal/pelvic surgery procedures. Patients were accrued in the prospective study AIROPROS 0102. Different types of surgery (rectum-sigma resection, kidney resection, cholecystectomy or appendectomy) were considered as covariates together with a number of different parameters previously found to be predictive of late toxicity and including clinical as well as dosimetric parameters. Univariate (UVA) and multivariate (MVA) logistic analyses were carried out. Results: In total 69/718 patients were previously submitted to one or more surgical procedures, mostly cholecystectomy (n = 21) and appendectomy (n = 27). Actuarial incidences of G2–G3 and G3 bleeding were 52 (7.2%) and 24 (3.3%) respectively; 19 (2.6%) chronic incontinence events were registered. Results: Cholecystectomy was found to be highly correlated with late rectal bleeding at UVA: OR = 4.3 and p = 0.006 for G2–G3 and OR = 5.4 and p = 0.01 for G3. Considering MVA (including dosimetric and clinical factors), G2–G3 bleeding was significantly correlated to cholecystectomy (OR = 6.5, p = 0.002), V75Gy (OR = 1.074, p = 0.003) and secondarily with appendectomy (OR = 2.7, p = 0.10), presence of acute radioinduced rectal bleeding (OR = 1.70, p = 0.21) and androgen deprivation (OR = 0.67, p = 0.25). Results: Appendectomy (OR = 5.9, p = 0.004) and cholecystectomy (OR = 5.5, p = 0.016) were very strong predictors of G3 bleeding with V75Gy playing a less significant role (OR = 1.037, p = 0.26). Conversely, no specific surgery was correlated with actuarial or chronic incontinence. Conclusions: This analysis highlights previous SURG as the best predictor of late rectal bleeding. Among the different types of abdominal surgery, cholecystectomy and appendectomy play the major role, especially for severe late bleeding.
📖 Papers frequently viewed together
626 Citations
332 Citations
54 Citations
References32
Newest
#1Riccardo ValdagniH-Index: 51
#2Michael W. Kattan (Cleveland Clinic Lerner College of Medicine)H-Index: 10
Last. C. Fiorino (UniSR: Vita-Salute San Raffaele University)H-Index: 7
view all 16 authors...
Purpose Development of user-friendly tools for the prediction of single-patient probability of late rectal toxicity after conformal radiotherapy for prostate cancer. Methods and Materials This multicenter protocol was characterized by the prospective evaluation of rectal toxicity through self-assessed questionnaires (minimum follow-up, 36 months) by 718 adult men in the AIROPROS 0102 trial. Doses were between 70 and 80 Gy. Nomograms were created based on multivariable logistic regression analysi...
38 CitationsSource
#1S. TomatisH-Index: 13
#2Tiziana RancatiH-Index: 27
Last. Riccardo ValdagniH-Index: 51
view all 16 authors...
The aim of this study was to develop a model exploiting artificial neural networks (ANNs) to correlate dosimetric and clinical variables with late rectal bleeding in prostate cancer patients undergoing radical radiotherapy and to compare the ANN results with those of a standard logistic regression (LR) analysis. 718 men included in the AIROPROS 0102 trial were analyzed. This multicenter protocol was characterized by the prospective evaluation of rectal toxicity, with a minimum follow-up of 36 mo...
32 CitationsSource
#1Gilles Defraene (Katholieke Universiteit Leuven)H-Index: 12
#2Laura Van den Bergh (Katholieke Universiteit Leuven)H-Index: 10
Last. Joos V. Lebesque (NKI-AVL: Netherlands Cancer Institute)H-Index: 76
view all 7 authors...
Purpose To study the impact of clinical predisposing factors on rectal normal tissue complication probability modeling using the updated results of the Dutch prostate dose-escalation trial. Methods and Materials Toxicity data of 512 patients (conformally treated to 68 Gy [ n = 284] and 78 Gy [ n = 228]) with complete follow-up at 3 years after radiotherapy were studied. Scored end points were rectal bleeding, high stool frequency, and fecal incontinence. Two traditional dose-based models (Lyman-...
54 CitationsSource
Purpose To model late fecal incontinence after high-dose prostate cancer radiotherapy (RT) in patients accrued in the AIROPROS (prostate working group of the Italian Association of Radiation Oncology) 0102 trial using different endpoint definitions. Methods and Materials The self-reported questionnaires (before RT, 1 month after RT, and every 6 months for ≤3 years after RT) of 586 patients were available. The peak incontinence (P_INC) and two longitudinal definitions (chronic incontinence [C_INC...
28 CitationsSource
#1Tiziana RancatiH-Index: 27
#2Claudio FiorinoH-Index: 54
Last. Riccardo ValdagniH-Index: 51
view all 12 authors...
Abstract Background and purpose To fit an NTCP model including clinical risk factors to late rectal toxicities after radiotherapy for prostate cancer. Methods and materials Data of 669 patients were considered. The probability of late toxicity within 36months (bleeding and incontinence) was fitted with the original and a modified Logit-EUD model, including clinical factors by fitting a subset specific TD 50 s: the ratio of TD 50 s with and without including the clinical variable was the dose-mod...
48 CitationsSource
#1Tahuanty Pena (WSU: Wayne State University)H-Index: 3
20 CitationsSource
#1Zhi Yi Ong (University of Adelaide)H-Index: 16
#2Rachel J. Gibson (University of Adelaide)H-Index: 42
Last. Dorothy M. K. KeefeH-Index: 55
view all 8 authors...
Background Mucositis is a toxic side effect of anti-cancer treatments and is a major focus in cancer research. Pro-inflammatory cytokines have previously been implicated in the pathophysiology of chemotherapy-induced gastrointestinal mucositis. However, whether they play a key role in the development of radiotherapy-induced gastrointestinal mucositis is still unknown. Therefore, the aim of the present study was to characterise the expression of pro-inflammatory cytokines in the gastrointestinal ...
120 CitationsSource
#1Amichay Meirovitz (HUJI: Hebrew University of Jerusalem)H-Index: 19
#2Michal Kuten (HUJI: Hebrew University of Jerusalem)H-Index: 1
Last. Vivian Barak (HUJI: Hebrew University of Jerusalem)H-Index: 47
view all 9 authors...
Background: The purpose of this pilot study was to detect a correlation between serum cytokine levels and severity of mucositis, necessitating installation of a percutaneous endoscopic gastrostomy tube (PEG) in head and neck (HN specifically, high IL-6 levels at week 2 were correlated with a need for PEG tube installation. A seemingly contradictory correlation was found between low IL-8 serum levels and a need for a PEG tube. Conclusion: These preliminary results, indicating a correlation betwee...
100 CitationsSource
#1Gianni FellinH-Index: 17
#2Claudio Fiorino (UniSR: Vita-Salute San Raffaele University)H-Index: 54
Last. Riccardo ValdagniH-Index: 51
view all 13 authors...
Abstract Purpose Assessing the predictors of late rectal toxicity after high-dose conformal radiotherapy for prostate cancer. Methods One thousand one hundred thirty-two patients entered a prospective observational multicentric study; late rectal toxicity was evaluated by a self-reported questionnaire. Results concerning bleeding and faecal incontinence of 718/1132 patients with a complete follow-up at 36 months were analysed. The correlation between a number of clinical–dosimetric parameters an...
96 CitationsSource
#1C. FiorinoH-Index: 7
#1Claudio FiorinoH-Index: 54
Last. Giuseppe Sanguineti (Johns Hopkins University)H-Index: 37
view all 4 authors...
A great deal of quantitative information regarding the dose–volume relationships of pelvic organs at risk has been collected and analysed over the last 10 years. The need to improve our knowledge in the modelling of late and acute toxicity has become increasingly important, due to the rapidly increasing use of inverse-planned intensity-modulated radiotherapy (IMRT) and the consequent need of a quantitative assessment of dose–volume or biological-based cost functions. This comprehensive review co...
332 CitationsSource
Cited By28
Newest
#1Kun-Peng Li (North Sichuan Medical College)
#2Xiaodong Yu (North Sichuan Medical College)
Last. Tao Wu (North Sichuan Medical College)H-Index: 5
view all 0 authors...
Purpose null Although single-port (SP) robot-assisted radical prostatectomy (SP-RARP) is considered a safe and feasible approach for radical prostatectomy, the comparative performance of the SP robot with earlier models, including da Vinci Xi or Si is elusive. This systematic review summarizes the current evidence on SP-RARP and compares its perioperative, functional, and oncologic outcomes to multiport robot-assisted radical prostatectomy (MP-RARP). null Methods null We performed a systematic s...
Source
Source
#1Soumyajit Roy (Ottawa Hospital)H-Index: 1
#1Soumyajit Roy (U of O: University of Ottawa)H-Index: 11
Last. Shawn Malone (U of O: University of Ottawa)H-Index: 29
view all 9 authors...
Abstract Purpose The impact of treating physician on radiation therapy (RT) related toxicity is unclear. We carried out a secondary analysis of a randomized controlled study to determine whether the risk of RT–related late toxicities in patients with prostate cancer varies depending on the treating radiation oncologist. Methods and Materials This is a secondary analysis of a phase 3 randomized controlled study in which patients with prostate cancer with Gleason score ≤7, clinical stage T1b-T3a, ...
Source
#1Louis Lenfant (University of Paris)H-Index: 3
#1Louis Lenfant (University of Paris)H-Index: 4
Last. Jihad H. Kaouk (Cleveland Clinic)H-Index: 98
view all 9 authors...
BACKGROUND Radical perineal prostatectomy (RPP) has been revived with the advent of single-port (SP) robotic surgery. However, its interest and precise role need to be evaluated and better defined. OBJECTIVE To describe in detail the technique of SP-RPP and compare initial perioperative outcomes with those of multiport robot-assisted transperitoneal radical prostatectomy (MP-RARP). DESIGN, SETTING, AND PARTICIPANTS From October 2018 to June 2020, perioperative data of 26 consecutive patients who...
2 CitationsSource
#1Rano Matta (U of T: University of Toronto)H-Index: 4
#1Rano Matta (Sunnybrook Health Sciences Centre)H-Index: 2
Last. Robert K. Nam (U of T: University of Toronto)H-Index: 54
view all 10 authors...
Abstract Context Radiotherapy used for treating localized prostate cancer is effective at prolonging cancer-specific and overall survival. Still, acute and late pelvic toxicities are a concern, with gastrointestinal (GI) and genitourinary (GU) sequelae being most common as well as other pelvic complications. Objective To present a critical review of the literature regarding the incidence and risk factors of pelvic toxicity following primary radiotherapy for prostate cancer and to provide a narra...
29 CitationsSource
#1Noorazrul Azmie Yahya (UKM: National University of Malaysia)H-Index: 7
#2Xin-Jane Chua (UKM: National University of Malaysia)H-Index: 1
Last. Fuad Ismail (UKM: National University of Malaysia)H-Index: 8
view all 4 authors...
Purpose This systematic review evaluates the completeness of dosimetric features and their inclusion as covariates in genetic-toxicity association studies.
7 CitationsSource
#1Maria Thor (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 16
#2Andrew Jackson (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 59
Last. Joseph O. Deasy (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 63
view all 11 authors...
Abstract Purpose To investigate whether inter-institutional cohort analysis uncovers more reliable dose–response relationships exemplified for late rectal bleeding (LRB) following prostate radiotherapy. Material and methods Data from five institutions were used. Rectal dose–volume histograms (DVHs) for 989 patients treated with 3DCRT or IMRT to 70–86.4 Gy@1.8–2.0 Gy/fraction were obtained, and corrected for fractionation effects ( α/β = 3 Gy). Cohorts with best-fit Lyman–Kutcher–Burman volume-ef...
9 CitationsSource
#1N. BediniH-Index: 5
#2Alessandro Cicchetti (UNIPV: University of Pavia)H-Index: 7
Last. Riccardo Valdagni (University of Milan)H-Index: 51
view all 16 authors...
A recent “hot topic” in prostate cancer radiotherapy is the observed association between acute/late rectal toxicity and the presence of abdominal surgery before radiotherapy. The exact mechanism is unclear. Our working hypothesis was that a previous surgery may influence plasma level of inflammatory molecules and this might result in enhanced radiosensitivity. We here present results on the feasibility of monitoring the expression of inflammatory molecules during radiotherapy. Plasma levels of a...
7 CitationsSource
#1Cesare CozzariniH-Index: 43
#2Tiziana RancatiH-Index: 27
Last. C. FiorinoH-Index: 7
view all 14 authors...
Abstract Background and purpose Urinary incontinence following radiotherapy (RT) for prostate cancer (PCa) has a relevant impact on patient’s quality of life. The aim of the study was to assess the unknown dose–effect relationship for late patient-reported urinary incontinence (LPRUI). Methods and materials Patients were enrolled within the multi-centric study DUE01. Clinical and dosimetry data including the prescribed 2 Gy equivalent dose (EQD2) were prospectively collected. LPRUI was evaluated...
12 CitationsSource
#1Maria JolnerovskiH-Index: 1
#2Julia SalleronH-Index: 35
Last. Ciprian ChiraH-Index: 3
view all 9 authors...
To report grade ≥2 overall late rectal and urinary toxicities in patients (pts) with prostate cancer treated by intensity-modulated radiotherapy (IMRT) at 3 dose-levels. Identify predictors of radiation toxicity and report biochemical progression free survival (bPFS). A total of 277 pts were treated with 70Gy (10.8%), 74Gy (63.9%) and 80 Gy (25.3%) using IMRT without pelvic irradiation were analyzed. Short or long-course androgen deprivation therapy (ADT) was allowed in 46.1% of pts. The toxicit...
9 CitationsSource